Published in J Neurol Neurosurg Psychiatry on June 01, 2001
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry (2005) 1.42
Peduncular hallucinosis: a syndrome of impaired reality monitoring. J Neurol (2006) 1.32
Altered resting state brain networks in Parkinson's disease. PLoS One (2013) 1.25
Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol (2005) 1.14
Hallucinations in Parkinson disease. Nat Rev Neurol (2009) 1.13
Parkinson's disease dementia: a neural networks perspective. Brain (2015) 1.10
Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. Schizophr Bull (2014) 0.99
A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease. BMC Neurol (2008) 0.99
Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS One (2011) 0.96
Quetiapine in the treatment of psychosis in Parkinson's disease. Ther Adv Neurol Disord (2010) 0.92
A randomized controlled trial of quetiapine for psychosis in Parkinson's disease. Neuropsychiatr Dis Treat (2009) 0.91
Visual hallucinatory syndromes: past, present, and future. Dialogues Clin Neurosci (2007) 0.90
Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study. BMC Neurol (2009) 0.88
Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol (2005) 0.88
Serotonergic dysfunction in Parkinson's disease and its relevance to disability. ScientificWorldJournal (2011) 0.85
Psychosis in Parkinson's disease. Postgrad Med J (2005) 0.84
Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations. Parkinsonism Relat Disord (2014) 0.81
Metabotropic glutamate receptor 5 negative modulation in phase I clinical trial: potential impact of circadian rhythm on the neuropsychiatric adverse reactions-do hallucinations matter? ISRN Psychiatry (2014) 0.79
Ophthalmological features of Parkinson disease. Med Sci Monit (2014) 0.78
Thought disorders among non-demented outpatients with Parkinson's disease: prevalence and associated factors. J Neural Transm (Vienna) (2010) 0.78
Effect of visual cues on the resolution of perceptual ambiguity in Parkinson's disease and normal aging. J Int Neuropsychol Soc (2015) 0.78
On visual hallucinations and cortical networks: a trans-diagnostic review. J Neurol (2015) 0.77
Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J Neurol (2007) 0.76
Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease. Mov Disord (2011) 0.76
Adenosine A(2A) Receptor Antagonists Do Not Disrupt Rodent Prepulse Inhibition: An Improved Side Effect Profile in the Treatment of Parkinson's Disease. Parkinsons Dis (2011) 0.76
Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress. Free Radic Biol Med (2017) 0.75
Frequency specific brain networks in Parkinson's disease and comorbid depression. Brain Imaging Behav (2017) 0.75
Changes of retina are not involved in the genesis of visual hallucinations in Parkinson's disease. Parkinsons Dis (2015) 0.75
Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease. Mov Disord Clin Pract (2017) 0.75
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis? NPJ Parkinsons Dis (2017) 0.75
Affective Correlates of Psychosis in Parkinson's Disease. Mov Disord Clin Pract (2016) 0.75
Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06
The fusiform face area: a module in human extrastriate cortex specialized for face perception. J Neurosci (1997) 22.73
Complex visual hallucinations. Clinical and neurobiological insights. Brain (1998) 2.96
Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet (1996) 2.67
Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain (2000) 2.23
Visual hallucinations associated with Parkinson disease. Arch Neurol (1996) 2.06
Visual hallucinations in patients with macular degeneration. Am J Psychiatry (1992) 1.75
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology (1998) 1.58
The Charles Bonnet syndrome: 'phantom visual images'. Perception (1991) 1.51
Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol (1999) 1.49
Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. Am J Psychiatry (1999) 1.48
Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry (1970) 1.45
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain (1987) 1.44
The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1985) 1.29
The functional neuroanatomy of implicit-motion perception or representational momentum. Curr Biol (2000) 1.28
The perceptual consequences of visual loss: 'positive' pathologies of vision. Brain (1999) 1.20
Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry (1978) 1.17
Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc (1991) 1.10
Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Ann Neurol (1987) 1.10
'Peduncular hallucinosis' following paramedian thalamic infarction. Neurology (1989) 1.09
A direct demonstration of functional specialization within motion-related visual and auditory cortex of the human brain. Curr Biol (1996) 1.07
Visuospatial dysfunction and problem solving in Parkinson's disease. Neuropsychology (1997) 1.04
Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 0.99
Visual hallucinations and sensory delusions in the elderly. Br J Psychiatry (1984) 0.98
Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology (1998) 0.97
Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 0.96
A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. Int Psychogeriatr (1997) 0.91
The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res (1995) 0.90
Visual hallucinations in a geriatric psychiatry clinic: prevalence and associated diagnoses. J Geriatr Psychiatry Neurol (1996) 0.86
Confusion, dementia and anticholinergics in Parkinson's disease. J Neurol Neurosurg Psychiatry (1982) 0.86
Meta-analytic comparison of the components of visual cognition in Parkinson's disease. J Clin Exp Neuropsychol (1995) 0.84
Hallucinations in Parkinson disease: neuropsychological study. Ital J Neurol Sci (1990) 0.84
Formal qualities of hallucinations: a comparative study of the visual hallucinations in patients with schizophrenic, organic, and affective psychoses. Proc Annu Meet Am Psychopathol Assoc (1966) 0.84
A study of visual hallucinations in patients with Parkinson's disease. J Neurol (1997) 0.83
Psychotic complications of long-term levodopa treatment of Parkinson's disease. Acta Neurol Scand (1991) 0.81
Neuropsychology of subcortical dementias. Psychiatr Clin North Am (1997) 0.81
Properties of complex hallucinations associated with deficits in vision. Perception (1996) 0.81
Visual hallucinations, white matter lesions and disease severity in Parkinson's disease. Acta Neurol Scand (1999) 0.79
Psychopathology of Parkinson's disease. Compr Psychiatry (1983) 0.78
Behavioral indicators of hallucinosis in levodopa-treated Parkinson's disease. Adv Neurol (1987) 0.77
Hallucinations following occipital lobe damage: the pathological activation of visual representations. J Clin Exp Neuropsychol (1994) 0.77
[Hallucinatory symptoms in Parkinson's disease during treatment with anti-parkinsonian drugs]. Rinsho Shinkeigaku (1986) 0.77
A specific neural substrate for perceiving facial expressions of disgust. Nature (1997) 5.12
Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry (2000) 4.84
Activation of auditory cortex during silent lipreading. Science (1997) 3.94
Abnormal monitoring of inner speech: a physiological basis for auditory hallucinations. Lancet (1995) 3.74
The auditory hallucination: a phenomenological survey. Psychol Med (1996) 2.54
The planum temporale: a systematic, quantitative review of its structural, functional and clinical significance. Brain Res Brain Res Rev (1999) 2.10
Measuring empathy: reliability and validity of the Empathy Quotient. Psychol Med (2004) 1.99
Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br J Psychiatry (2001) 1.96
Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study. Br J Psychiatry (2001) 1.93
Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry (2001) 1.75
Adverse life events and breast cancer: case-control study. BMJ (1995) 1.74
Response amplification in sensory-specific cortices during crossmodal binding. Neuroreport (1999) 1.68
Cortical substrates for the perception of face actions: an fMRI study of the specificity of activation for seen speech and for meaningless lower-face acts (gurning). Brain Res Cogn Brain Res (2001) 1.66
Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer (2000) 1.66
Arousal dissociates amygdala and hippocampal fear responses: evidence from simultaneous fMRI and skin conductance recording. Neuroimage (2001) 1.62
Towards a functional neuroanatomy of self processing: effects of faces and words. Brain Res Cogn Brain Res (2000) 1.62
Chronic fatigue in primary care attenders. Psychol Med (1993) 1.60
Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am J Psychiatry (1997) 1.58
Do psychiatric registrars take a proper drinking history? Br Med J (Clin Res Ed) (1988) 1.50
The legend of Camelford: medical consequences of a water pollution accident. J Psychosom Res (1995) 1.46
Functional anatomy of inner speech and auditory verbal imagery. Psychol Med (1996) 1.41
Chronic fatigue syndrome and related disorders in UK veterans of the Gulf War 1990-1991: results from a two-phase cohort study. Psychol Med (2007) 1.40
Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. Am J Psychiatry (1997) 1.38
Recognizing one's own face. Cognition (2001) 1.37
A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry Res (1999) 1.36
Searching for a Gulf War syndrome using cluster analysis. Psychol Med (2002) 1.36
Common and distinct neural substrates for pragmatic, semantic, and syntactic processing of spoken sentences: an fMRI study. J Cogn Neurosci (2000) 1.35
A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med (1998) 1.34
The human amygdala: a systematic review and meta-analysis of volumetric magnetic resonance imaging. Brain Res Brain Res Rev (2002) 1.28
The functional neuroanatomy of implicit-motion perception or representational momentum. Curr Biol (2000) 1.28
An investigation into the perception of dominance from schematic faces: a study using the World-Wide Web. Behav Res Methods Instrum Comput (1999) 1.27
The health effects of peace-keeping in the UK Armed Forces: Bosnia 1992-1996. Predictors of psychological symptoms. Psychol Med (2003) 1.26
Obstetric complications and risk of schizophrenia. Effect of gender, age at diagnosis and maternal history of psychosis. Br J Psychiatry (2001) 1.24
Psychiatrists' attitudes to maintenance medication for patients with schizophrenia. Psychol Med (2003) 1.22
Meta-analysis of corpus callosum size in schizophrenia. J Neurol Neurosurg Psychiatry (1995) 1.21
Investigation of facial recognition memory and happy and sad facial expression perception: an fMRI study. Psychiatry Res (1998) 1.20
The epidemiology of depersonalisation and derealisation. A systematic review. Soc Psychiatry Psychiatr Epidemiol (2004) 1.20
The impact of early and late damage to the human amygdala on 'theory of mind' reasoning. Brain (2004) 1.16
Reduced sensitivity to linguistic context in schizophrenic thought disorder: evidence from on-line monitoring for words in linguistically anomalous sentences. J Abnorm Psychol (1998) 1.14
The role of 'shared representations' in social perception and empathy: an fMRI study. Neuroimage (2005) 1.13
Depersonalization disorder: thinking without feeling. Psychiatry Res (2001) 1.13
Mental capacity, diagnosis and insight in psychiatric in-patients: a cross-sectional study. Psychol Med (2008) 1.09
Neuropsychological study of motor neuron disease. Psychosomatics (1986) 1.07
Silent speechreading in the absence of scanner noise: an event-related fMRI study. Neuroreport (2000) 1.07
Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years. J Psychopharmacol (2009) 1.06
Intelligence and schizophrenia. Acta Psychiatr Scand (1999) 1.04
Facial processing in schizophrenia and delusional misidentification: cognitive neuropsychiatric approaches. Schizophr Res (1995) 1.00
Scholastic achievement at age 16 and risk of schizophrenia and other psychoses: a national cohort study. Psychol Med (2007) 1.00
Brain activation during automatic and controlled processing of semantic relations: a priming experiment using lexical-decision. Neuropsychologia (2001) 0.99
Are depot antipsychotics more coercive than tablets? The patient's perspective. J Psychopharmacol (2009) 0.99
The functional anatomy of imagining and perceiving colour. Neuroreport (1998) 0.99
Agenesis of the corpus callosum and schizophrenia: a case report. Psychol Med (1988) 0.98
Neural correlates of thinking in sign language. Neuroreport (1997) 0.98
Differential effects of lesions of the amygdala and prefrontal cortex on recognizing facial expressions of complex emotions. J Cogn Neurosci (2005) 0.96
Culture and insight revisited. Br J Psychiatry (2004) 0.96
Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med (2003) 0.95
Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia (2003) 0.95
Antipsychotic depot medication and attitudes of community psychiatric nurses. J Psychiatr Ment Health Nurs (2005) 0.94
Outcome in the chronic fatigue syndrome. BMJ (1992) 0.94
Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behav Res Ther (2003) 0.94
Sensitivity to linguistic anomalies in spoken sentences: a case study approach to understanding thought disorder in schizophrenia. Psychol Med (2000) 0.94
Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study. Br J Psychiatry (2000) 0.93
Visual scan paths are abnormal in deluded schizophrenics. Neuropsychologia (1997) 0.92
Perception of threat in schizophrenics with persecutory delusions: an investigation using visual scan paths. Psychol Med (2000) 0.92
Dispersed activation in the left temporal cortex for speech-reading in congenitally deaf people. Proc Biol Sci (2001) 0.92
Audio-visual speech perception in schizophrenia: an fMRI study. Psychiatry Res (2001) 0.92
Corpus callosum size and inter-hemispheric function in schizophrenia. Schizophr Res (1997) 0.91
Disgust--the forgotten emotion of psychiatry. Br J Psychiatry (1998) 0.91
Cognitive neuropsychiatry: towards a scientific psychopathology. Nat Rev Neurosci (2001) 0.91
What do psychiatric inpatients really want? BMJ (1989) 0.90
'I thought it would go away': patient denial in breast cancer. J R Soc Med (1992) 0.90
Lamotrigine in the treatment of depersonalization disorder. J Clin Psychiatry (2001) 0.89
Viewing strategies for simple and chimeric faces: an investigation of perceptual bias in normals and schizophrenic patients using visual scan paths. Brain Cogn (1997) 0.88
Regaining mental capacity for treatment decisions following psychiatric admission: a clinico-ethical study. Psychol Med (2010) 0.88
Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia. Acta Neurol Scand (1987) 0.88
Separating depersonalisation and derealisation: the relevance of the "lesion method". J Neurol Neurosurg Psychiatry (2002) 0.87
Emotional memory and perception in temporal lobectomy patients with amygdala damage. J Neurol Neurosurg Psychiatry (2004) 0.87
Improving performance on the WCST: variations on the original procedure. Wisconsin Card Sorting Test. Schizophr Res (1997) 0.87
Insight in eating disorders: clinical and cognitive correlates. Psychol Med (2011) 0.86
A prospective study of the effects of anterior temporal lobectomy on emotion recognition and theory of mind. Neuropsychologia (2007) 0.86
Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework. Eur J Neurol (2011) 0.86
Are auditory hallucinations the consequence of abnormal cerebral lateralization? A morphometric MRI study of the sylvian fissure and planum temporale. Biol Psychiatry (2001) 0.86
Cognitive behaviour therapy for common mental disorders in people with Multiple Sclerosis: A bench marking study. Behav Res Ther (2013) 0.85
Psychotic states arising in late life (late paraphrenia) psychopathology and nosology. Br J Psychiatry (1995) 0.85
Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors. J Neurol Neurosurg Psychiatry (2004) 0.85
Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: a 123I-iomazenil SPET study. Biol Psychiatry (1998) 0.85
Domains of awareness in schizophrenia. Schizophr Bull (2010) 0.85
Religious faith after psychotic illness. Psychopathology (1998) 0.84
Neuroimaging in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry (1996) 0.84
Agenesis of the corpus callosum: a United Kingdom series of 56 cases. J Neurol Neurosurg Psychiatry (1998) 0.84
Is semantic fluency differentially impaired in schizophrenic patients with delusions? J Clin Exp Neuropsychol (1999) 0.83
The functional anatomy of the McCollough contingent colour after-effect. Neuroreport (1999) 0.83
Evidence for heterogeneous forms of the snake venom metalloproteinase jararhagin: a factor contributing to snake venom variability. Arch Biochem Biophys (2003) 0.83
Patterns of referral in patients with medically unexplained motor symptoms. J Psychosom Res (2000) 0.83
Unsuccessful treatment of Creutzfeldt-Jakob disease with acyclovir. Lancet (1984) 0.83
The relationship between cognitive inhibition and psychotic symptoms. J Abnorm Psychol (2000) 0.82
Corpus callosum area and functioning in schizophrenic patients with auditory--verbal hallucinations. Schizophr Res (2001) 0.81
Is auditory imagery defective in patients with auditory hallucinations? Psychol Med (2000) 0.81
Cognitive neuropsychiatry? Psychol Med (1993) 0.81
Cortical activity during rotational and linear transformations. Neuropsychologia (2000) 0.81